Early Access

10-QPeriod: Q2 FY2003

HCA Healthcare, Inc. Quarterly Report for Q2 Ended Jun 30, 2003

Filed August 11, 2003For Securities:HCA

Summary

HCA Healthcare, Inc.'s (HCA) second-quarter 2003 report shows a significant decrease in net income, down 31.4% to $240 million compared to $350 million in the prior year's quarter. This decline was impacted by a substantial increase in the provision for doubtful accounts, which rose to $577 million from $371 million, reflecting challenges in collecting receivables, particularly from uninsured patients. The company also recorded a significant $130 million impairment charge related to the discontinuation of a patient accounts receivable management system. Despite the net income decrease, revenues saw a healthy increase of 11.5% to $5.47 billion, driven by a combination of acquisitions, increased patient volumes (up 4.5% in admissions), and improved revenue per equivalent admission. The acquisition of the Health Midwest hospital system in Kansas City contributed to the revenue growth. Management is focused on improving operating efficiencies, cost management, and expanding its network of services. The company also continues to navigate significant legal and regulatory matters, having recently settled remaining investigation issues with the Department of Justice and CMS, albeit with substantial financial outlays.

Key Highlights

  • 1Net income for the quarter decreased by 31.4% year-over-year to $240 million.
  • 2Revenues increased by 11.5% to $5.47 billion, supported by acquisitions and volume growth.
  • 3The provision for doubtful accounts significantly increased by $206 million year-over-year, indicating collection challenges.
  • 4A $130 million impairment charge was recognized due to the discontinuation of a patient accounts receivable management system.
  • 5HCA completed the acquisition of the Health Midwest hospital system, adding 11 hospitals.
  • 6The company resolved significant government investigations with substantial payments made in July 2003.
  • 7Stock repurchases continued, with $394 million spent in the second quarter under new and existing authorizations.

Frequently Asked Questions